ClinicalTrials.Veeva

Menu

The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Hemodialysed Patients With Impaired Liver Enzymes

Study type

Observational

Funder types

Other

Identifiers

NCT01054664
nephrop003

Details and patient eligibility

About

To assess the incidence of occult hepatitis C virus in hemodialysed patients with mild impairment of liver enzymes

Full description

occult hepatitis C virus will be checked in monocytes of hemodialyzed patients with permanent mild impairment of liver enzymes This population has no evidence of hepatitis B or C according to standard laboratory tests (HVC antibodies,HCV PCR, hepatitis B antibodies) Hepatitis C virus RNA will be performed in peripheral blood mononuclear cells of hemodialysed patients

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hemodialysed patients with impaired liver enzymes

Exclusion criteria

  • hepatitis B and C positive

Trial design

30 participants in 3 patient groups

impaired liver enzymes
normal liver enzymes
hepatitis C antibodies positive

Trial contacts and locations

1

Loading...

Central trial contact

Eleonora Plotkin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems